Great to see the malaria elimination message on a Melbourne billboard!The chilly weather may mislead, but ending malaria is relevant to Aussies. Malaria Congress ACREME Asia Pacific Leaders Malaria Alliance x.com/globalfund/sta…

A demonstration of how collaboration can assist in improving the tools we have to control malaria. #malaria #malariaelimination WWARN @wwarnnews.bsky.social Ric Price Menzies Research

Plus for the last 60 years, we have probably been under-dosing chloroquine for #vivax malaria !

Major breakthrough for vivax malaria. First new drug to treat dormant liver stage and prevent relapse in 60 years. #malaria #malariaelimination

Second indication for tafenoquine also approved by the FDA. This time for prevention #malaria prnewswire.com/news-releases/…

“Malaria is very clever — it hides out where you don’t know and comes back when you aren’t ready" - candid story on the risk of drug resistant malaria in the Mekong region. moru Amy Maxmen, PhD #malaria #malariaelimination nature.com/articles/d4158…

The IMPROV trial out today in The Lancet. 7d vs 14d high dose Primaquine for #vivax malaria - 7d as effective as 14d with acceptable tolerance. The shorter course regimen offers hope of a more practical regimen for the radical cure of #malaria thelancet.com/journals/lance…

New research from Rob Commons Ric Price in PLOS Medicine supports co-administration of primaquine with artemisinin-based combination therapies for P. vivax #malaria wwarn.org/news/news-arti… Photo: UNICEF, Iman Morooka

Estimating the Proportion of #Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis buff.ly/2UsqDAS Ric Price Menzies Research Charles Darwin University @BallaratHealth University of Melbourne Science at Melbourne MORU @jwato_watson Tropical Medicine Oxford ASTMH

Important The Lancet Infectious Diseases study by Sutanto et al doi.org/10.1016/S1473-… that led to label change for tafenoquine to not be administered with ACTs #vivax #malaria. Commentary by Kamala Thriemer & I highlights need for further studies in different populations doi.org/10.1016/S1473-…

Great to see results from the #INSPECTOR study out in The Lancet Infectious Diseases doi.org/10.1016/S1473-…. Tafenoquine (TQ) with ACTs showed low efficacy in Papua, Indonesia and results already led to a label change. Was this too premature? A thread (1/4)